Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Chemotherapy (CT) & Non-small-cell lung cancer (NSCLC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

This review suggested an increase in neoadjuvant and adjuvant chemotherapy with increasing stage, generally in line with treatment guidelines.
Waser et al. 2022 Future Oncol. 18(12): 1519-1530

…

References (Sources)

Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer
Pirker 2020a Current Opinion in Oncology 32(1): 63-67
Review
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer
Aix et al. 2020

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Chemotherapy (CT) & Non-small-cell lung cancer (NSCLC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat